Sensitivity of Mycobacterium leprae to Telacebec

The treatment of leprosy is long and complex, benefiting from the development of sterilizing, rapidly-acting drugs. Reductive evolution made Mycobacterium leprae exquisitely sensitive to Telacebec, a phase 2 drug candidate for tuberculosis(.) The unprecedented potency of Telacebec against M. leprae...

Descripción completa

Detalles Bibliográficos
Autores principales: Lahiri, Ramanuj, Adams, Linda B., Thomas, Sangeeta Susan, Pethe, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888226/
https://www.ncbi.nlm.nih.gov/pubmed/35202539
http://dx.doi.org/10.3201/eid2803.210394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888226/
https://www.ncbi.nlm.nih.gov/pubmed/35202539
http://dx.doi.org/10.3201/eid2803.210394

Ejemplares similares